The Dana-Farber Cancer Institute reported by the Stand Up To Cancer-Prostate Cancer Foundation Dream Team published a new study in the journal, Cell. The findings target a potential new drug therapy for treating prostate cancer. It's the first study of the genomic composition of prostate cancer.